Information Sessions – Demineralized Bone Matrix (DBM)
There have been certain changes to our offer of demineralized bone matrix (DBM) products since our sole human tissue distributor mandate came into effect on December 2, 2024. We have identified a need for training on this product family, based on the preliminary data we gathered on distribution trends since the mandate has come into effect, and on conversations with some of our consultants.
To address this need, Héma-Québec has put together a series of information sessions on DBM products, in collaboration with LifeNet Health (February 24 and 25, 2025) and Bioventus, for the OsteoAMP line (March 19 and 20, 2025).
These sessions were developed to help participants better understand our products and to present the products introduced to Québec (LifeNet Health) since our sole distributor mandate took effect. Héma-Québec also wanted to understand how we can support the healthcare system in a needs-based approach to selecting these products.
These sessions were an invaluable opportunity to ask questions and talk to our team of experts. You can watch the LifeNet Health DBM information session, in French only, to learn more.
Statement by Dr. Marc Germain – Héma-Québec’s sole human tissus distributor mandate
On April 11, 2024, we announced that Héma-Québec’s sole human tissue distributor mandate will officially enter into force on December 2, 2024. As of that date, Héma-Québec will be solely responsible for supplying and distributing human tissue across the entire Québec health care network, thereby consolidating its role in delivering human tissue products.
Please be assured that as a strategic partner of Québec’s health and social services network, Héma-Québec is committed to going above and beyond for our shared mission of providing Quebecers with high-quality human tissue.
Héma-Québec is proud to be tasked with this mandate by the Ministère de la Santé et des Services sociaux. Watch the statement from Dr. Marc Germain, Vice-President of Medical Affairs and Innovation at Héma-Québec.
Information sessions
Starting on December 2, 2024, Héma-Québec will become the sole distributor of human tissue in Québec. This centralization process will simplify supply management in order to better meet hospitals’ needs, enhance patient safety and improve traceability for human tissue and how it is used.
Your role and expertise are vital to Héma-Québec’s success in this mandate, and so your involvement in the continuous improvement process for distributing human tissue is critically important.
To that end, Héma-Québec held information sessions in September and October 2024 about its new role as the sole distributor of human tissue. Recordings of these information sessions are available below (in French only).